Menu Search
Equities

Integer Holdings Corp

ITGR:NYQ

Integer Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)136.89
  • Today's Change-2.60 / -1.86%
  • Shares traded200.16k
  • 1 Year change+61.75%
  • Beta1.1126
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Integer Holdings Corp grew revenues 16.03% from 1.38bn to 1.60bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 36.57% net income growth from 66.38m to 90.65m.
Gross margin27.06%
Net profit margin6.81%
Operating margin11.59%
Return on assets3.81%
Return on equity7.42%
Return on investment4.10%
More ▼

Cash flow in USDView more

In 2023, Integer Holdings Corp did not generate a significant amount of cash. However, the company earned 180.21m from its operations for a Cash Flow Margin of 11.29%. In addition the company used 163.37m on investing activities and also paid 18.01m in financing cash flows.
Cash flow per share6.30
Price/Cash flow per share21.14
Book value per share48.33
Tangible book value per share-6.47
More ▼

Balance sheet in USDView more

Integer Holdings Corp has a Debt to Total Capital ratio of 40.28%, a lower figure than the previous year's 64.84%.
Current ratio3.28
Quick ratio2.09
Total debt/total equity0.6744
Total debt/total capital0.4028
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 37.07%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)8.57
EPS (TTM) vs
TTM 1 year ago		37.55
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.